Photo: Associated Press

If Martin Shkreli, the young hedge fund manager-turned-pharmaceutical executive who made news last month by jacking up the price of a life-saving medication by 5,000 percent, was surprised by the scorn his decision provoked, it was because his behavior was rather common. 

That’s according to an analysis released by Hedge Clippers, an activist group that exposes what it views as predatory behavior by Hedge Fund managers. In its report, the group points to evidence that hedge funds and private equity firms have been the driving force behind exponential increases in drug prices. 

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?

Jack Craver



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.